Press release
Global Pulmonary Arterial Hypertension Market Report 2022 | By Size, Share, Scope, Demand, Overview And Top Key Players Are Bayer AG, Gilead Sciences Inc., GlaxoSmithKline, Pfizer Inc., Sandoz AG
Pulmonary Arterial Hypertension Market Size
The regions covered in the pulmonary arterial hypertension market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest pulmonary arterial hypertension market share.
Request For A Sample Of The Pulmonary Arterial Hypertension Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5954&type=smp
The pulmonary arterial hypertension market consists of sales of drugs by entities (organizations, sole proprietors, partnerships) that are used in the treatment of pulmonary arterial hypertension disease, which is a rare progressive disorder characterized by high blood pressure in the arteries of lungs. During this medical condition walls of the pulmonary arteries thicken and stiffen, making it difficult for the blood to flow through the lungs. The pulmonary arterial hypertension drugs relax the muscles in the wall of the blood vessels or increase the blood flow through the lungs or reverse the effect of the substance in the walls of blood vessels, which caused them to narrow.
Key competitors in the pulmonary arterial hypertension market include United Therapeutics Corporation, Bayer AG, Gilead Sciences Inc., Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Acceleron Pharma Inc., Eli Lilly and Company, Actelion Pharmaceuticals US Inc, Natco Pharma Ltd, Zydus Pharmaceutical USA, and Liquidia Technologies Inc.
The global pulmonary arterial hypertension market is expected to grow from $6.59 billion in 2021 to $7.04 billion in 2022 at a compound annual growth rate (CAGR) of 6.85%. The pulmonary arterial hypertension market is expected to reach $9.65 billion in 2026 at a CAGR of 8.22%.
Need More For Your Business Growth? Directly Purchase The Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5954
TBRC's Report Segments The Global Pulmonary Arterial Hypertension Market:
1) By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators
2) By Route of Administration: Oral, Intravenous/ subcutaneous, Inhalational
3) By Distribution channel: Retail, Online
Read Further On The Pulmonary Arterial Hypertension Market Here:
https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report
The Table Of Contents Includes:
1. Executive Summary
2. Pulmonary Arterial Hypertension Market Characteristics
3. Pulmonary Arterial Hypertension Market Trends And Strategies
4. Impact Of COVID-19 On Pulmonary Arterial Hypertension
5. Pulmonary Arterial Hypertension Market Size And Growth
.....
26. Africa Pulmonary Arterial Hypertension Market
27. Pulmonary Arterial Hypertension Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Pulmonary Arterial Hypertension Market
29. Pulmonary Arterial Hypertension Market Future Outlook And Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
And check out our Blog: http://blog.tbrc.info/
Interested To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pulmonary Arterial Hypertension Market Report 2022 | By Size, Share, Scope, Demand, Overview And Top Key Players Are Bayer AG, Gilead Sciences Inc., GlaxoSmithKline, Pfizer Inc., Sandoz AG here
News-ID: 2643184 • Views: …
More Releases from The Business research company
Segment Analysis and Major Growth Areas in the Isoflavones Market
The isoflavones market is poised for remarkable growth over the coming years, driven by increasing consumer awareness and expanding applications across various industries. With rising interest in health supplements and natural ingredients, this market is attracting significant attention from manufacturers and investors alike. Let's delve into the market's size, key players, emerging trends, and segment breakdowns shaping its trajectory.
Projected Market Size and Growth Outlook for Isoflavones
The isoflavones market…
Key Strategic Developments and Emerging Changes Shaping the Infant Nutrition Mar …
The infant nutrition market is on track for substantial expansion in the coming years, driven by evolving consumer preferences and advancements in product offerings. As parents increasingly seek high-quality nutrition solutions tailored to their babies' needs, the sector is poised for remarkable growth through innovative products and diverse distribution channels. Let's explore the market's size projections, key players, emerging trends, and segment breakdowns shaping this dynamic industry.
Projected Growth Trajectory and…
Leading Companies Advancing Innovation and Growth in the Immune Health Supplemen …
The immune health supplements sector is gaining significant traction as consumers increasingly prioritize wellness and preventive care. With a growing interest in personalized nutrition and plant-based options, this market is set to expand rapidly. Let's explore the expected market size, key players, emerging trends, and segmentation that define the future of immune health supplements.
Projected Expansion of the Immune Health Supplements Market by 2030
The immune health supplements market is…
Honey Spread Market Overview: Major Segments, Strategic Developments, and Leadin …
The honey spread market is gaining significant momentum as consumers increasingly seek healthier and more flavorful alternatives to traditional spreads. Growing awareness around natural ingredients and sustainability, combined with e-commerce expansion and innovative product offerings, is set to shape the future of this sector. Below, we explore the market's size, key players, emerging trends, and segmentation to provide a comprehensive outlook through 2030.
Robust Expansion Expected in the Honey Spread Market…
More Releases for Pulmonary
Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,…
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
